Voya Investment Management LLC Dexcom Inc Transaction History

Voya Investment Management LLC

  • $82.2 Billion
  • Q3 2025

A detailed history of Voya Investment Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 108,485 shares of DXCM stock, worth $6.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
108,485
Previous 616,067 82.39%
Holding current value
$6.3 Million
Previous $53.8 Million 86.43%
% of portfolio
0.01%
Previous 0.07%

Shares

45 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025
SELL
$66.46 - $89.53 $33.7 Million - $45.4 Million
-507,582 Reduced 82.39%
108,485 $7.3 Million
Q2 2025

Aug 14, 2025
BUY
$59.83 - $87.57 $149,575 - $218,924
2,500 Added 0.41%
616,067 $53.8 Million
Q1 2025

May 15, 2025
SELL
$67.74 - $90.75 $451,012 - $604,213
-6,658 Reduced 1.07%
613,567 $41.9 Million
Q4 2024

Feb 14, 2025
SELL
$65.68 - $81.01 $22.4 Million - $27.7 Million
-341,756 Reduced 35.53%
620,225 $48.2 Million
Q3 2024

Feb 07, 2025
SELL
$64.0 - $116.06 $22 Million - $39.9 Million
-344,081 Reduced 26.34%
961,981 $64.5 Million
Q3 2024

Nov 14, 2024
SELL
$64.0 - $116.06 $22 Million - $40 Million
-344,278 Reduced 26.36%
961,981 $64.5 Million
Q2 2024

Feb 07, 2025
SELL
$110.31 - $140.45 $167 Million - $212 Million
-1,511,549 Reduced 53.65%
1,306,062 $148 Million
Q2 2024

Dec 03, 2024
BUY
$110.31 - $140.45 $38 Million - $48.3 Million
344,081 Added 35.77%
1,306,062 $148 Million
Q2 2024

Aug 14, 2024
SELL
$110.31 - $140.45 $167 Million - $212 Million
-1,512,708 Reduced 53.66%
1,306,259 $148 Million
Q1 2024

Feb 07, 2025
BUY
$114.22 - $140.1 $212 Million - $260 Million
1,855,630 Added 192.9%
2,817,611 $391 Million
Q1 2024

Dec 06, 2024
BUY
$114.22 - $140.1 $212 Million - $260 Million
1,855,630 Added 192.9%
2,817,611 $391 Million
Q1 2024

May 15, 2024
SELL
$114.22 - $140.1 $55.9 Million - $68.6 Million
-489,733 Reduced 14.8%
2,818,967 $391 Million
Q4 2023

Feb 07, 2025
BUY
$75.49 - $124.16 $51.4 Million - $84.5 Million
680,928 Added 25.91%
3,308,700 $411 Million
Q4 2023

Feb 14, 2024
BUY
$75.49 - $124.16 $51.4 Million - $84.5 Million
680,928 Added 25.91%
3,308,700 $411 Million
Q3 2023

Feb 07, 2025
BUY
$86.06 - $137.93 $37.6 Million - $60.2 Million
436,722 Added 19.93%
2,627,772 $245 Million
Q3 2023

Nov 14, 2023
BUY
$86.06 - $137.93 $37.6 Million - $60.2 Million
436,722 Added 19.93%
2,627,772 $245 Million
Q2 2023

Feb 07, 2025
SELL
$112.47 - $130.98 $84.3 Million - $98.2 Million
-749,804 Reduced 25.5%
2,191,050 $282 Million
Q2 2023

Aug 14, 2023
SELL
$112.47 - $130.98 $84.3 Million - $98.2 Million
-749,804 Reduced 25.5%
2,191,050 $282 Million
Q1 2023

Feb 07, 2025
BUY
$104.0 - $122.92 $206 Million - $243 Million
1,978,873 Added 205.71%
2,940,854 $342 Million
Q1 2023

May 15, 2023
SELL
$104.0 - $122.92 $86.9 Million - $103 Million
-835,921 Reduced 22.13%
2,940,854 $342 Million
Q4 2022

Feb 07, 2025
SELL
$84.98 - $122.67 $57.6 Million - $83.1 Million
-677,349 Reduced 15.21%
3,776,775 $428 Million
Q4 2022

Feb 14, 2023
SELL
$84.98 - $122.67 $57.6 Million - $83.1 Million
-677,349 Reduced 15.21%
3,776,775 $428 Million
Q3 2022

Feb 07, 2025
BUY
$76.35 - $94.18 $267 Million - $329 Million
3,492,143 Added 363.02%
4,454,124 $359 Million
Q3 2022

Mar 03, 2023
BUY
$76.35 - $94.18 $51.7 Million - $63.8 Million
677,349 Added 17.93%
4,454,124 $359 Million
Q3 2022

Nov 14, 2022
BUY
$76.35 - $94.18 $115 Million - $142 Million
1,510,296 Added 51.3%
4,454,124 $409 Million
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $153 Million - $299 Million
2,248,804 Added 323.56%
2,943,828 $219 Million
Q1 2022

May 16, 2022
BUY
$94.08 - $130.2 $3.73 Million - $5.17 Million
39,677 Added 6.05%
695,024 $356 Million
Q4 2021

Feb 14, 2022
SELL
$129.87 - $162.82 $30.4 Million - $38.1 Million
-233,964 Reduced 26.31%
655,347 $352 Million
Q3 2021

Nov 15, 2021
SELL
$106.71 - $143.18 $3.36 Million - $4.5 Million
-31,462 Reduced 3.42%
889,311 $486 Million
Q2 2021

Aug 16, 2021
BUY
$80.99 - $107.93 $21.4 Million - $28.5 Million
263,957 Added 40.19%
920,773 $393 Million
Q1 2021

May 17, 2021
BUY
$84.79 - $104.74 $3 Million - $3.7 Million
35,368 Added 5.69%
656,816 $236 Million
Q4 2020

Feb 16, 2021
BUY
$78.0 - $104.5 $44.9 Million - $60.2 Million
575,814 Added 1261.81%
621,448 $230 Million
Q3 2020

Nov 16, 2020
BUY
$95.51 - $112.95 $360,263 - $426,047
3,772 Added 9.01%
45,634 $18.8 Million
Q2 2020

Aug 14, 2020
SELL
$62.68 - $105.34 $36.3 Million - $61 Million
-579,542 Reduced 93.26%
41,862 $17 Million
Q1 2020

May 15, 2020
SELL
$47.79 - $75.63 $23.9 Million - $37.7 Million
-499,087 Reduced 44.54%
621,404 $167 Million
Q4 2019

Feb 14, 2020
SELL
$36.62 - $57.29 $6.81 Million - $10.7 Million
-186,079 Reduced 14.24%
1,120,491 $245 Million
Q3 2019

Nov 14, 2019
BUY
$35.53 - $43.8 $2.19 Million - $2.69 Million
61,506 Added 4.94%
1,306,570 $195 Million
Q2 2019

Aug 14, 2019
BUY
$27.84 - $38.92 $34 Million - $47.5 Million
1,219,588 Added 4787.2%
1,245,064 $187 Million
Q1 2019

May 15, 2019
SELL
$28.07 - $38.18 $42,105 - $57,270
-1,500 Reduced 5.56%
25,476 $3.03 Million
Q4 2018

Feb 14, 2019
BUY
$26.99 - $37.37 $1,619 - $2,242
60 Added 0.22%
26,976 $3.23 Million
Q3 2018

Nov 14, 2018
SELL
$23.35 - $36.72 $13,309 - $20,930
-570 Reduced 2.07%
26,916 $3.85 Million
Q2 2018

Aug 14, 2018
SELL
$17.54 - $25.22 $61,442 - $88,345
-3,503 Reduced 11.3%
27,486 $2.61 Million
Q1 2018

May 15, 2018
SELL
$13.06 - $18.54 $4,571 - $6,489
-350 Reduced 1.12%
30,989 $2.3 Million
Q4 2017

Feb 14, 2018
SELL
$11.12 - $15.38 $14,244 - $19,701
-1,281 Reduced 3.93%
31,339 $1.8 Million
Q3 2017

Nov 14, 2017
BUY
$11.36 - $18.98 $370,563 - $619,127
32,620
32,620 $1.6 Million

Others Institutions Holding DXCM

# of Institutions
1,091
Shares Held
445M
Call Options Held
6.78M
Put Options Held
7.25M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email